Activation of the mammalian target of rapamycin signaling pathway underlies a novel inhibitory role of ring finger protein 182 in ventricular remodeling after myocardial ischemia-reperfusion injury.

Wang, Jing-Hua; Wei, Zhi-Feng; Gao, Yan-Li; Liu, Cong-Cong; Sun, Jing-Hui

Wang, Jing-Hua; Wei, Zhi-Feng; Gao, Yan-Li; Liu, Cong-Cong; Sun, Jing-Hui.

Afiliación

Wang JH; Department of Pediatric Rheumatology, Immunology and Allergy, The First Hospital of Jilin University, Changchun, China.
Wei ZF; Department of Cardiology, FAW General Hospital, Changchun, China.
Gao YL; Department of Science and Education, The First Hospital of Jilin University, Changchun, China.
Liu CC; Department of Pediatric Rheumatology, Immunology and Allergy, The First Hospital of Jilin University, Changchun, China.
Sun JH; Department of Pediatric Cardiology, The First Hospital of Jilin University, Changchun, China.

J Cell Biochem ; 120(5): 7635-7648, 2019 May.

Article en En | MEDLINE | ID: mdl-30450663

Palabras clave

gene silencing; mammalian target of rapamycin (mTOR) signaling pathway; myocardial ischemia-reperfusion injury (MIRI); ring finger protein 182 (RNF182); ventricular remodeling

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cell Biochem Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google